Profile data is unavailable for this security.
About the company
ImmuneOnco Biopharmaceuticals Shanghai Inc is a China-based company mainly engaged in the development of tumor immunotherapy. The Company's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The Company's core product IMM01 is an innovative CD47-targeted molecule. The Company mainly operates its businesses in the domestic and overseas markets.
- Revenue in HKD (TTM)127.39m
- Net income in HKD-343.97m
- Incorporated2015
- Employees195.00
- LocationImmuneOnco Biopharmaceuticals Shanghai IncSHANGHAI ChinaCHN
- Phone+86 2 138016387
- Websitehttp://immuneonco.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JW (Cayman) Therapeutics Co Ltd | 202.00m | -701.87m | 803.79m | 292.00 | -- | 0.778 | -- | 3.98 | -1.69 | -1.69 | 0.4868 | 2.48 | 0.1046 | 1.34 | 9.59 | 718,847.30 | -36.34 | -35.14 | -47.41 | -39.06 | 55.52 | -- | -347.47 | -898.77 | 1.45 | -1,808.42 | 0.2907 | -- | -8.99 | -- | 23.10 | -- | -32.98 | -- |
| Sunho Biologics Inc | 0.00 | -93.28m | 961.93m | 128.00 | -- | 1.76 | -- | -- | -0.6181 | -0.6181 | 0.00 | 3.49 | 0.00 | -- | -- | 0.00 | -14.33 | -- | -15.84 | -- | -- | -- | -- | -- | 6.57 | -- | 0.1242 | -- | -- | -- | 39.74 | -- | -- | -- |
| Brii Biosciences Ltd | 0.00 | -426.94m | 1.05bn | 96.00 | -- | 0.3693 | -- | -- | -0.5865 | -0.5865 | 0.00 | 3.93 | 0.00 | -- | -- | 0.00 | -14.05 | -49.92 | -14.09 | -54.57 | -- | -- | -- | -12,750.27 | -- | -- | 0.003 | -- | -100.00 | -- | -190.66 | -- | -33.13 | -- |
| B&K Corp Ltd | 296.60k | -207.53m | 1.05bn | 100.00 | -- | 10.91 | -- | 3,534.44 | -1.76 | -1.76 | 0.0025 | 0.8165 | -- | -- | -- | -- | -- | -- | -- | -- | 92.34 | -- | -69,968.59 | -- | -- | -- | 0.0371 | -- | -44.70 | -- | -101.78 | -- | -- | -- |
| HighTide Therapeutics Inc | 0.00 | -330.88m | 1.11bn | 57.00 | -- | 2.79 | -- | -- | -0.7319 | -0.7319 | 0.00 | 0.6965 | 0.00 | -- | -- | 0.00 | -49.50 | -- | -63.55 | -- | -- | -- | -- | -- | -- | -- | 0.2129 | -- | -- | -- | 59.35 | -- | -- | -- |
| Kintor Pharmaceutical Ltd | 12.48m | -189.86m | 1.21bn | 136.00 | -- | 4.41 | -- | 96.68 | -0.4389 | -0.4389 | 0.0289 | 0.5485 | 0.0194 | 10.66 | 1.06 | 74,299.69 | -29.53 | -47.72 | -44.54 | -55.96 | -55.12 | -36.16 | -1,521.00 | -8,974.73 | 0.4222 | -33.76 | 0.2881 | -- | -- | -- | 85.36 | -- | -53.11 | -- |
| Wuhan YZY Biopharma Co Ltd | 164.78m | -88.68m | 1.39bn | 106.00 | -- | -- | -- | 8.41 | -0.4575 | -0.4575 | 0.85 | -0.1609 | 0.5805 | 11.54 | 13.96 | 1,458,228.00 | -31.24 | -- | -133.35 | -- | 63.96 | -- | -53.82 | -- | 0.9019 | -24.38 | 1.21 | -- | -- | -- | 49.09 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -253.99m | 1.45bn | 173.00 | -- | -- | -- | -- | -0.4538 | -0.4538 | 0.00 | -0.2891 | 0.00 | -- | -- | 0.00 | -37.04 | -36.20 | -186.73 | -45.67 | -- | -- | -- | -- | 0.0712 | -6.63 | 1.48 | -- | -- | -- | 44.18 | -- | 5.95 | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 127.39m | -343.97m | 1.53bn | 195.00 | -- | 2.38 | -- | 12.02 | -0.8744 | -0.8744 | 0.3236 | 1.49 | 0.148 | -- | 3,865.48 | 816,606.60 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Cloudbreak Pharma Inc | 78.21m | -327.17m | 1.73bn | 60.00 | -- | -- | -- | 22.07 | -0.39 | -0.39 | 0.0932 | -3.08 | -- | -- | -- | 1,533,510.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| Mabpharm Ltd | 481.76m | -31.23m | 1.77bn | 383.00 | -- | 15.78 | 47.87 | 3.68 | -0.0076 | -0.0076 | 0.1168 | 0.0272 | 0.4209 | 0.4659 | 4.05 | 1,529,387.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
| Antengene Corp Ltd | 95.86m | -259.78m | 1.96bn | 152.00 | -- | 2.25 | -- | 20.41 | -0.418 | -0.418 | 0.1543 | 1.28 | 0.0619 | 1.51 | 3.20 | 567,217.40 | -16.77 | -48.14 | -19.52 | -53.06 | 78.54 | -- | -271.00 | -1,460.93 | 4.41 | -- | 0.2346 | -- | 36.62 | -- | 45.07 | -- | 259.46 | -- |
| Jiangsu Recbio Technology Co Ltd | 12.39m | -743.11m | 2.17bn | 507.00 | -- | 10.56 | -- | 175.47 | -1.56 | -1.56 | 0.0259 | 0.4262 | 0.006 | -- | -- | 23,325.33 | -36.26 | -31.31 | -64.03 | -37.31 | -- | -- | -5,990.59 | -- | 0.2767 | -100.74 | 0.8254 | -- | -- | -- | 1.67 | -- | 16.82 | -- |
| Frontage Holdings Corp | 1.98bn | 29.99m | 2.24bn | 1.54k | 74.42 | 0.8384 | 7.11 | 1.13 | 0.0148 | 0.0148 | 0.9742 | 1.31 | 0.4545 | 60.36 | 3.97 | 1,268,440.00 | 0.6902 | 3.05 | 0.8654 | 3.64 | 27.78 | 32.14 | 1.52 | 6.84 | 1.22 | 1.97 | 0.2861 | 0.00 | -1.90 | 20.48 | -92.68 | -46.72 | 13.29 | -- |
Data as of Mar 05 2026. Currency figures normalised to ImmuneOnco Biopharmaceuticals Shanghai Inc's reporting currency: Hong Kong Dollar HKD
1.73%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 3.28m | 0.78% |
| E Fund Management Co., Ltd.as of 30 Jun 2025 | 1.78m | 0.42% |
| SSgA Funds Management, Inc.as of 05 Feb 2026 | 958.20k | 0.23% |
| HuaAn Fund Management Co., Ltd.as of 30 Jun 2025 | 405.00k | 0.10% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 399.00k | 0.10% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 282.40k | 0.07% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 100.00k | 0.02% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2025 | 84.00k | 0.02% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
| China Asset Management Co., Ltd.as of 30 Jun 2025 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
